On the other hand, an insulin-resistance and obesity-related systemic metabolic milieu is known to enhance GRK2 upregulation [13,15], whereas a better-preserved metabolic homeostasis seems to attenuate such a HFD-mediated increase in GRK2 levels. Here, GRK2 is linked to obesity due to melanocortin 4 receptor deficiency.